Barber, GN STING: Infection, inflammation, and cancer. Nat. Pastor Immunol. 15760–770 (2015).
Srikanth, S. et al. Canada2+ The sensor STIM1 regulates type I interferon responses by maintaining the signaling adapter STING in the endoplasmic reticulum. Nat. immune. 20152–162(2019).
Li, S. et al. Long-term activation of innate immune pathways by multivalent STING agonists. Nat. Biomed. english 5455–466 (2021).
Corrales, L. et al. Direct activation of STING in the tumor microenvironment induces robust and systemic tumor regression and immunity. cell representative 111018~1030 (2015).
Li, L. et al. Design of hydrolyzed and non-hydrolyzable analogues of 2'3'-cGAMP by ENPP1. Nat. chemistry. Biol. 101043–1048 (2014).
Shae, D. et al. Endolytic polymersomes enhance cancer immunotherapy by increasing the activity of cyclic dinucleotide STING agonists. Nat. Nanotechnology. 14269–278(2019).
Kato, K. et al. Structural insights into cGAMP cleavage by the ecto-nucleotide pyrophosphatase phosphodiesterase 1. Nat. Common. 91–8 (2018).
Pan, B.-S. except. An oral non-nucleotide STING agonist with antitumor activity. science 369eaba6098(2020).
Chin, EN et al. Antitumor activity of systemic STING-activating non-nucleotide cGAMP mimetics. science 369993–999 (2020).
Konno, H. et al. Inhibition of STING signaling through epigenetic silencing and missense mutations disrupts DNA damage-mediated cytokine production. oncogene 372037~2051 (2018).
Xia, T., Konno, H. & Barber, G.N. Recurrent loss of STING signaling in melanoma correlates with susceptibility to viral oncolysis. cancer lips. 766747-6759(2016).
Tse, S.-W. except. STINGV155M, encoded by mRNA and constitutively active, is a potent genetic adjuvant of antigen-specific CD8.+ T cell response. mole. there. 292227~2238(2021).
Hong, C. et al. cGAS-STING promotes IL-6-dependent survival of chromosomal instability cancers. nature 607366–373 (2022).
Tu, X. et al. Disruption of trafficking after Golgi STING activates tonic interferon signaling. Nat. Common. 136977(2022).
Zhang, C. et al. Structural basis of STING binding and phosphorylation by TBK1. nature 567394–398 (2019).
Shang, G., Zhang, C., Chen, Z.J., Bai, X.-c & Zhang, X. Cryo-EM structure of STING reveals activation mechanism by cyclic GMP-AMP. nature 567389–393 (2019).
Zhao, B. et al. The conserved PLPLRT/SD motif of STING mediates the recruitment and activation of TBK1. nature 569718–722 (2019).
Wang, C., Sharma, N., Kessler, P.M. & Sen, GC interferon induction by STING requires translocation to late endosomes. traffic 24576–586 (2023).
Wang, C. et al. STING-mediated interferon induction by herpes simplex virus 1 requires the protein tyrosine kinase Syk. Gyeongju 12e03228–03221 (2021).
Li, C. et al. Innate and adaptive immune mechanisms against the Pfizer-BioNTech BNT162b2 vaccine. Nat. immune. 23543–555 (2022).
Stetefeld, J. et al. Crystal structure of a naturally occurring parallel right-handed coiled-coil tetramer. Nat. struct. Biol. 7772-776(2000).
Wu, J., Dobbs, N., Yang, K. & Yan, N. Interferon-independent activity of mammalian STING mediates antiviral responses and tumor immune evasion. immune 53115–126 (2020).
Barber, GN STING-dependent cytoplasmic DNA sensing pathway. Trend immunity. 3588–93 (2014).
De Oliveira Mann, CC et al. The modular architecture of the STING C-terminal tail allows adaptation to interferon and NF-κB signaling. cell representative 27, 1165-1175. e1165(2019).
Abe, T. & Barber, G.N. Cytosolic-DNA-mediated, STING-dependent induction of proinflammatory genes requires canonical NF-κB activation through TBK1. J. Birol. 885328-5341(2014).
Liu, T., Zhang, L., Joo, D. & Sun, S.-C. NF-κB signaling in inflammation. Signal transmission. Target. there. 21–9 (2017).
Tak, PP & Firestein, GS NF-κB: a key role in inflammatory diseases. J. Clean. Investigate. 1077–11 (2001).
Xu, J. et al. Precise targeting of POLR2A as a therapeutic strategy for human triple-negative breast cancer. Nat. Nanotechnology. 14388–397 (2019).
Hotz, C. et al. Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication in several preclinical tumor models. science. translation. Med. 13eabc7804(2021).
Hewitt, S.L. et al. Sustained anticancer immunity resulting from intratumoral administration of IL-23, IL-36γ, and OX40L mRNA. science. translation. Med. 11eaat9143(2019).
Akita, H. Development of SS cleavable pH-activated lipid-like material (ssPalm) as a nucleic acid delivery device. Biol. Pharmaceutical Bull. 431617~1625 (2020).
Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnology. 15313–320 (2020).
Augustine, C. et al. Blood parameters of Wistar albino rats fed processed tropical sickle pods (Senna obtusifolia) leaf-based diet. translation. animated film. science. 4778–782 (2020).
Marcus, A. et al. Tumor-derived cGAMP activates NK cell responses by triggering STING-mediated interferon responses in non-tumor cells. immune 49754–763 (2018).
Li, W. et al. cGAS-STING-mediated DNA sensing maintains CD8+ Promotes T cell stem cell formation and anti-tumor T cell therapy. science. translation. Med. 12eaay9013(2020).
Krishna, S. et al. Stem-like CD8 T cells mediate responses to adoptive cell immunotherapy for human cancer. science 3701328~1334 (2020).
Tkach, M. & Théry, C. Communication through extracellular vesicles: Where we are and where we need to go. cell 1641226-1232(2016).
Torralba, D. et al. Priming of dendritic cells by DNA-containing extracellular vesicles from T cells activated through antigen-driven contact. Nat. Common. 92658(2018).
Ishii, H. et al. miR-130a and miR-145 reprogram Gr-1.+ CD11b+ Inhibits tumor metastasis through myeloid cells and enhanced host immunity. Nat. Common. 92611(2018).
Yang, J. et al. MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of the Fra-1 proto-oncogene. oncogene 333014~3023(2014).
Ji, Y., Hocker, J. D. & Gattinoni L. in Immunology Seminar (edited by Kroemer, G. & Mantovani, A.) 45–53 (Elsevier, 2016).
Lee, S. Y. et al. Wnt/Snail signaling regulates cytochrome c oxidase and glucose metabolism. Mitochondrial and metabolic regulation by Wnt/Snail. cancer lips. 723607-3617(2012).
Stemmer, V., De Craene, B., Berx, G. & Behrens, J. Snail promotes Wnt target gene expression and interacts with β-catenin. oncogene 275075-5080 (2008).
Xu, X., Zhang, M., Xu, F. & Jiang, S. Wnt signaling in breast cancer: biological mechanisms, challenges, and opportunities. mole. cancer 1935(2020).
Tokar, T. et al. mirDIP 4.1—an integrated database of human microRNA target predictions. Nucleic acid resolution. 46D360–D370 (2018).
Hashiba A. et al. Use of experimental design with multiple reactions to determine the optimal formulation for in vivo hepatic mRNA delivery. J. Control. release 327467–476 (2020).
Sabnis, S. et al. A new series of amino lipids for mRNA delivery: improving endosomal escape and sustaining pharmacology and safety in non-human primates. mole. there. 261509~1519 (2018).